lariam mefloquine 250mg tablets
pharmaco australia ltd - mefloquine hydrochloride, quantity: 274.09 mg (equivalent: mefloquine, qty 250 mg) - tablet, uncoated - excipient ingredients: ammonium alginate; crospovidone; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified talc; maize starch; poloxamer - malaria treatment: lariam is indicated for the treatment of acute attacks of malaria due to p.falciparum infection resistant to conventional antimalarial drugs. following therapy of mixed p.falciparum/p.vivax malaria with lariam relapse prophylaxis with an 8-aminoquinoline derivative (e.g. primaquine) should be considered in order to eliminate liver forms of p.vivax. malaria prophylaxis: for travellers to countries with documented chloroquine and antifolate combination ( [sulfadoxine/pyrimethamine] / [dapsone/pyrimethamine] ) resistant p.falciparum malaria, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas (between the dusk to dawn period). for travellers hypersensitive to sulphonamides and sulphones, who are considered to be at high risk for malaria in view of their residence or travel (of up to 3 months duration) through rural areas, (between the dusk to dawn period) in countries with high level chloroquine-resistant p.fal
sulfadoxine
intervet australia pty limited - sulfadoxine - unknown - sulfadoxine sulfanyl active 0.0 - active constituent
daraprim pyrimethamine tablet
kaiser foundation hospitals - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - pyrimethamine 25 mg
daraprim pyrimethamine tablet
amedra pharmaceuticals llc - pyrimethamine (unii: z3614qox8w) (pyrimethamine - unii:z3614qox8w) - pyrimethamine 25 mg
sulfadoxine
randlab australia pty ltd - sulfadoxine - unknown - sulfadoxine sulfanyl active 0.0 - active constituent
sulfadoxine
bimeda (australia) pty. limited - sulfadoxine - unknown - sulfadoxine sulfanyl active 0.0 - active constituent
sulfadoxine
avet health limited - sulfadoxine - unknown - sulfadoxine sulfanyl active 0.0 - active constituent
wimal 250/12.5mg dispersible tablet
universal corporation limited club road, plot number 13777,p.o box 1748-00902 - sulfadoxine and pyrimethamine - dispersible tablet - each dispersible tablets contains sulfadoxine - pyrimethamine combinations
wimal plus hs dispersible tablets 500/150/25
universal corporation limited, kenya - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 500/150/25
wimal plus hs dispersible tablets 250/12.5 mg and 75 mg
universal corporation limited, kenya - sulfadoxine/pyrimethamine/amodiaquine (as hydrochloride) - dispersible tablets - 250/12.5 mg and 75 mg